Cardiology, Cardiovascular and Heart Surgery
Almost half the American population suffers from one or more types of cardio-vascular disease. Approximately 3.4 million people undergo cardiac catheterization procedures alone every year. Clinics and hospitals are investing substantial resources in new technologies for heart treatment, diagnostic and research purposes. With an increasing trend towards intervention procedures worldwide, many updated procedures are designed to reduce the need for open heart surgery on patients. The so-called keyhole procedures now replace to an ever greater extent operations that previously required open heart surgery.
Advanced medical technology promises greater improvements in patient care, allowing for earlier diagnosis of malfunctions, greater effectiveness in monitoring functionality, less invasive surgery, shorter hospital stays and faster recovery times. Intelligent and well timed product development, focusing on the needs of high-tech, cardiology and heart surgery, is the key to a demanding market. QLT specialists help prepare new products and provide a first-class selling venue in this market.
